Signal Transducer and Activator of Transcription 5 Activation Is Sufficient to Drive Transcriptional Induction of Cyclin D2 Gene and Proliferation of Rat Pancreatic β-Cells
The DOI matches its Crossref record; 75 of the 78 references it cites were found in a registry or an index.
Abstract
Signal transducer and activator of transcription 5 (STAT5) activation plays a central role in GH- and prolactin-mediated signal transduction in the pancreatic β-cells. In previous experiments we demonstrated that STAT5 activation is necessary for human (h)GH-stimulated proliferation of INS-1 cells and hGH-induced increase of mRNA-levels of the cell cycle regulator cyclin D2. In this study we have further characterized the role of STAT5 in the regulation of cyclin D expression and β-cell proliferation by hGH. Cyclin D2 mRNA and protein levels (but not cyclin D1 and D3) were induced in a time-dependent manner by hGH in INS-1 cells. Inhibition of protein synthesis by coincubation with cycloheximide did not affect the hGH-induced increase of cyclin D2 mRNA levels at 4 h. Expression of a dominant negative STAT5 mutant, STAT5aΔ749, partially inhibited cyclin D2 protein levels. INS-1 cells transiently transfected with a cyclin D2 promoter-reporter construct revealed a 3- to 5-fold increase of transcriptional activity in response to hGH stimulation. Furthermore, coexpression of a constitutive active STAT5 mutant (either CA-STAT5a or CA-STAT5b) was sufficient to drive transactivation of the promoter. CA-STAT5b was stably expressed in INS-1 cells under the control of a doxycycline-inducible promoter. Gel retardation experiments using a probe representing a putative STAT5 binding site in the cyclin D2 promoter revealed binding of the doxycycline-induced CA-STAT5b. Furthermore, induction of CA-STAT5b stimulated transcriptional activation of the cyclin D2 promoter and induced hGH-independent proliferation in these cells. In primary β-cells, adenovirus-mediated expression of CA-STAT5b profoundly stimulated DNA-synthesis (5.3-fold over control) in the absence of hGH. Our studies indicate that STAT5 activation is sufficient to drive proliferation of the β-cells and that cyclin D2 may be a critical target gene for STAT5 in this process.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cish and Socs2 decrease activation of STAT5 [67,68], which has both pro-proliferative (Cyclin D2) [69] and anti-apoptotic (Bcl-xl, Bcl6) targets, as well as targets involved in β-cell function (Figure 3) [56,70].”
From Expansion of β-cell mass in response to pregnancy (2010) · cites this paper as [69]
Citations
Cites
Structural design and molecular evolution of a cytokine receptor superfamily.
Bazan, J. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.6934 · Cited by 2,069 · cited 1×
“tor superfamily (18), which upon activation associates”
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Disruption of IRS-2 causes type 2 diabetes in mice
Withers, D. J., Gutierrez, J. S., Towery, H., Burks, D. J., Ren, J.-M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775
Teglund, S., McKay, C., Schuetz, E., van Deursen, J. M., Stravopodis, D., Wang, D., Brown, M., Bodner, S., Grosveld, G., & Ihle, J. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81444-0 · Cited by 1,267 · cited 1×
“STAT5a is highly expressed in the mammary gland relative to STAT5b (68, 69), which may explain why STAT5adeficient mice show incomplete mammopoiesis and failure of lactogenesis but remain indistinguishable from wild-type mice in size, weight, and fertility (68).”
BackgroundStat5a is mandatory for adult mammary gland development and lactogenesis.
Liu, X., Robinson, G. W., Wagner, K. U., Garrett, L., Wynshaw-Boris, A., & Hennighausen, L. (1997) · Genes & Development · doi:10.1101/gad.11.2.179 · Cited by 1,111 · cited 1×
“STAT5a is highly expressed in the mammary gland relative to STAT5b (68, 69), which may explain why STAT5adeficient mice show incomplete mammopoiesis and failure of lactogenesis but remain indistinguishable from wild-type mice in size, weight, and fertility (68).”
BackgroundD-type cyclin-dependent kinase activity in mammalian cells.
Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., & Kato, J. Y. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2066 · Cited by 1,064 · cited 2×
“The D-type cyclins, D1–D3, act as growth factor sensors for the transition of cells from G1 phase to Sphase depending on extracellular mitogenic signals (28, 29).”
BackgroundRequirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression
Udy, G. B., Towers, R. P., Snell, R. G., Wilkins, R. J., Park, S.-H., Ram, P. A., Waxman, D. J., & Davey, H. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7239 · Cited by 988 · cited 1×
“On the other hand, the STAT5b isoform is highly expressed in the liver relative to STAT5a (71), which may explain the defects in sexual dimorphism of liver gene expression in STAT5bdeficient mice (72).”
BackgroundRane, S. G., Dubus, P., Mettus, R. V., Galbreath, E. J., Boden, G., Reddy, E. P., & Barbacid, M. (1999) · Nature Genetics · doi:10.1038/8751 · Cited by 700
Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis
Sicinski, P., Donaher, J. L., Geng, Y., Parker, S. B., Gardner, H., Park, M. Y., Robker, R. L., Richards, J. S., McGinnis, L. K., Biggers, J. D., et al. (1996) · Nature · doi:10.1038/384470a0 · Cited by 697
Mice lacking cyclin D1 are small and show defects in eye and mammary gland development.
Fantl, V, Stamp, G., Andrews, A., Rosewell, I., & Dickson, C. (1995) · Genes & Development · doi:10.1101/gad.9.19.2364 · Cited by 691
Pelengaris, S., Khan, M., & Evan, G. I. (2002) · Cell · doi:10.1016/s0092-8674(02)00738-9 · Cited by 626
Gouilleux, F., Wakao, H., Mundt, M., & Groner, B. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06756.x · Cited by 588 · cited 2×
“The INS-1 cell clones, EB03, BB32 [described previously, (21)], and 1*6–18 were cultured in the media described above plus 100 g/ml hygromycin B.”
BackgroundLiu, X., Robinson, G. W., Gouilleux, F., Groner, B., & Hennighausen, L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8831 · Cited by 557 · cited 3×
“and b) encoded by different genes are highly homologous and share 96% sequence similarity at the protein level (20).”
BackgroundStat5 Is Required for IL-2-Induced Cell Cycle Progression of Peripheral T Cells
Moriggl, R., Topham, D. J., Teglund, S., Sexl, V., McKay, C., Wang, D., Hoffmeyer, A., van Deursen, J., Sangster, M. Y., Bunting, K. D., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80025-4 · Cited by 547
Sorenson, R., & Brelje, T. (1997) · Hormone and Metabolic Research · doi:10.1055/s-2007-979040 · Cited by 531
Kubota, N., Tobe, K., Terauchi, Y., Eto, K., Yamauchi, T., Suzuki, R., Tsubamoto, Y., Komeda, K., Nakano, R., Miki, H., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1880 · Cited by 521
Regulation of pancreatic β-cell growth and survival by the serine/threonine protein kinase Akt1/PKBα
Tuttle, R. L., Gill, N. S., Pugh, W., Lee, J.-P., Koeberlein, B., Furth, E. E., Polonsky, K. S., Naji, A., & Birnbaum, M. J. (2001) · Nature Medicine · doi:10.1038/nm1001-1133 · Cited by 511
Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27
Bouchard, C. (1999) · The EMBO Journal · doi:10.1093/emboj/18.19.5321 · Cited by 502 · cited 2×
“3 kb of the mouse cyclin D2 promoter into the SacI site of the pGL2-basic vector (33).”
BackgroundNosaka, T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.17.4754 · Cited by 491 · cited 1×
“This could be due to an inhibition of JAK activity by members of the suppressor of cytokine signaling/cytokine-inducible inhibitor of signaling (CIS) family of genes that has also been shown for the Ba/F3expressing CA-STAT5 cells, where enforced JAKbinding protein/suppressor of cytokine signaling-1 (SOCS-1), but not C…”
BackgroundParsons, J. A. (1992) · Endocrinology · doi:10.1210/en.130.3.1459 · Cited by 476 · cited 1×
“with secretion of PL (12), and the expression of the”
BackgroundCell-cycle inhibitors: three families united by a common cause
Vidal, A., & Koff, A. (2000) · Gene · doi:10.1016/s0378-1119(00)00092-5 · Cited by 431 · cited 1×
“CDK4 and 6 are coexpressed in many cell types and appear, to some extent, to have redundant functions (62).”
BackgroundButeau, J., Roduit, R., Susini, S., & Prentki, M. (1999) · Diabetologia · doi:10.1007/s001250051238 · Cited by 413
Onishi, M., Nosaka, T., Misawa, K., Mui, A. L.-F., Gorman, D., McMahon, M., Miyajima, A., & Kitamura, T. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.3871 · Cited by 412
Brelje, T. C. (1993) · Endocrinology · doi:10.1210/en.132.2.879 · Cited by 408 · cited 10×
“948 Mol Endocrinol, May 2003, 17(5):945–958 Friedrichsen et al.”
BackgroundResultInfluentialRegulation of cyclin-Cdk activity in mammalian cells
Obaya, A. J., & Sedivy, J. M. (2002) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-002-8410-1 · Cited by 397 · cited 2×
“Cyclin D2 protein was undetectable after 4 h of CX treatment of INS-1 cells, indicating a rapid turnover consistent with observations in other cell types where cyclin Ds are found to be transiently induced and degraded during the cell cycle with a half-life of 10–30 min, depending on the cell type (61).”
BackgroundLarner, J., Pohl, S. L., & Clarke, W. L. (1984) · Wiley eBooks · Cited by 363
Matsumura, I. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1367 · Cited by 332
A MORPHOLOGICAL STUDY OF THE ENDOCRINE PANCREAS IN HUMAN PREGNANCY
Van Assche, F. A., Aerts, L., & Prins, F. D. (1978) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1978.tb15835.x · Cited by 267
Freemark, M. (2002) · Endocrinology · doi:10.1210/en.143.4.1378 · Cited by 258 · cited 1×
“Novel studies in the PRLR-deficient mice show that the islet size and -cell mass are reduced (14) and, in addition, reduced -cell proliferation in diabetic GK rats correlates with impaired PRL secretion (15).”
BackgroundThe Retinoblastoma Protein Pathway in Cell Cycle Control and Cancer
Bartek, J., Bartkova, J., & Lukas, J. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3776 · Cited by 254 · cited 1×
“During G1 phase of the cell cycle, these cyclins associate with catalytic subunits, cyclin-dependent-kinase (CDK) 4 or 6, leading to phosphorylation and inactivation of the key substrate retinoblastoma protein, pRb, followed by release and activation of the transcription factor family, E2F, important for S-phase activ…”
BackgroundButeau, J., Foisy, S., Rhodes, C. J., Carpenter, L., Biden, T. J., & Prentki, M. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2237 · Cited by 252
Self-citationTrümper, A., Trümper, K., Trusheim, H., Arnold, R., Göke, B., & Hörsch, D. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.9.0688 · Cited by 238
Regulation of beta-cell mass by hormones and growth factors.
Nielsen, J. H., Galsgaard, E. D., Møldrup, A., Friedrichsen, B. N., Billestrup, N., Hansen, J. A., Lee, Y. C., & Carlsson, C. (2001) · Diabetes · doi:10.2337/diabetes.50.2007.s25 · Cited by 235
Self-citationLiu, X. (1996) · Molecular Endocrinology · doi:10.1210/me.10.12.1496 · Cited by 231 · cited 1×
“Even though STAT5a and STAT5b can form heterodimers upon tyrosine phosphorylation (22) and bind to the same DNA sequences, individual transcriptional regulation of genes has been detected (23–25).”
BackgroundGrowth Hormone Activation of Stat 1, Stat 3, and Stat 5 in Rat Liver
Ram, P. A., Park, S.-H., Choi, H. K., & Waxman, D. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5929 · Cited by 226 · cited 1×
“On the other hand, the STAT5b isoform is highly expressed in the liver relative to STAT5a (71), which may explain the defects in sexual dimorphism of liver gene expression in STAT5bdeficient mice (72).”
BackgroundVasavada, R. C., Garcia-Ocaña, A., Zawalich, W. S., Sorenson, R. L., Dann, P., Syed, M., Ogren, L., Talamantes, F., & Stewart, A. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.20.15399 · Cited by 212
Soldaini, E., John, S., Moro, S., Bollenbacher, J., Schindler, U., & Leonard, W. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.389-401.2000 · Cited by 212 · cited 1×
“The STATs can furthermore bind as tetramers through dimer-dimer interaction to tandem-linked GAS motifs (26), which further increase the opportunities to diverge in different systems.”
BackgroundPancreatic Beta-cell growth and diabetes mellitus
Swenne, I. (1992) · Diabetologia · doi:10.1007/bf00400917 · Cited by 201
Bartkova, J., Lukas, J., Strauss, M., & Bartek, J. (1998) · Oncogene · doi:10.1038/sj.onc.1202016 · Cited by 190 · cited 2×
“Cyclin D1–D3 are closely related proteins that are differently expressed in a wide variety of organs in a tissue-specific manner (29).”
BackgroundSTAT5-Dependent CyclinD1 and Bcl-xL Expression in Bcr-Abl-Transformed Cells
de Groot, R. P., Raaijmakers, J. A. M., Lammers, J. J., & Koenderman, L. (2000) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.2000.0231 · Cited by 172 · cited 1×
“Studies in human hematopoietic cells have shown that cyclin D1 can be a direct target gene for STAT5 in response to cytokine treatment (63, 64), and it was shown recently that PRL-induced activation of the human cyclin D1 promoter (which contains two consensus sequences for PRL-induced STAT binding) depend on STAT5 bi…”
BackgroundPRL Activates the Cyclin D1 Promoter Via the Jak2/Stat Pathway
Brockman, J. L. (2002) · Molecular Endocrinology · doi:10.1210/me.16.4.774 · Cited by 163 · cited 1×
“Studies in human hematopoietic cells have shown that cyclin D1 can be a direct target gene for STAT5 in response to cytokine treatment (63, 64), and it was shown recently that PRL-induced activation of the human cyclin D1 promoter (which contains two consensus sequences for PRL-induced STAT binding) depend on STAT5 bi…”
BackgroundNIELSEN, J. H. (1982) · Endocrinology · doi:10.1210/endo-110-2-600 · Cited by 161
Self-citationMammary Gland Development in Prolactin Receptor Knockout Mice
Ormandy, C. J., Binart, N., & Kelly, P. A. (1997) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1026395229025 · Cited by 160
Verdier, F., Rabionet, R., Gouilleux, F., Beisenherz-Huss, C., Varlet, P., Muller, O., Mayeux, P., Lacombe, C., Gisselbrecht, S., & Chretien, S. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5852 · Cited by 157
Beta cell proliferation and growth factors
Nielsen, J. H., Svensson, C., Galsgaard, E. D., Møldrup, A., & Billestrup, N. (1999) · Journal of Molecular Medicine · doi:10.1007/s001090050302 · Cited by 135
Self-citationModulation of glucose responsiveness of insulinoma β-cells by graded overexpression of glucokinase
Wang, H., & Iynedjian, P. B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4372 · Cited by 127
Møldrup, A., Petersen, E. D., & Nielsen, J. H. (1993) · Endocrinology · doi:10.1210/endo.133.3.8365359 · Cited by 115
Self-citationGrowth Hormone is a Growth Factor for the Differentiated Pancreatic β-Cell
Nielsen, J. H., Linde, S., Welinder, B. S., Billestrup, N., & Madsen, O. D. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-1-165 · Cited by 114
Self-citationStat5 and Sp1 Regulate Transcription of the Cyclin D2 Gene in Response to IL-2
Martino, A., Holmes, J. H., Lord, J. D., Moon, J. J., & Nelson, B. H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1723 · Cited by 106 · cited 1×
“An IL-2-regulated functional STAT-5 binding site was recently identified at position 1199 to 1191 of the human cyclin D2 promoter (67).”
BackgroundIdentification of a growth hormone-responsive STAT5-binding element in the rat insulin 1 gene
Galsgaard, E. D. (1996) · Molecular Endocrinology · doi:10.1210/me.10.6.652 · Cited by 101
Self-citationIGF-I and GH post-receptor signaling mechanisms for pancreatic beta-cell replication
Rhodes, C. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0240303 · Cited by 93
Self-citationProlactin receptors and JAK2 in islets of Langerhans: an immunohistochemical analysis
Sorenson, R. L., & Stout, L. E. (1995) · Endocrinology · doi:10.1210/en.136.9.4092 · Cited by 85 · cited 1×
“Limiting components in STAT5 activation may be the GHR and/or PRLR, which previously have been shown to be heterogeneously expressed within the islets (74).”
BackgroundFriedrichsen, B. N. (2001) · Molecular Endocrinology · doi:10.1210/me.15.1.136 · Cited by 79
Self-citationHerrington, J., Rui, L., Luo, G., Yu-Lee, L.-Y., & Carter-Su, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.5138 · Cited by 78
Insulin Administration Enhances Growth of the β-Cell Mass in Streptozotocin-Treated Newborn Rats
Movassat, J., Saulnier, C., & Portha, B. (1997) · Diabetes · doi:10.2337/diab.46.9.1445 · Cited by 75
Swenne, I., Bone, A. J., Howell, S. L., & Hellerström, C. (1980) · Diabetes · doi:10.2337/diab.29.9.686 · Cited by 71
Regulation of Prolactin Receptor (PRLR) Gene Expression in Insulin-producing Cells
Galsgaard, E. D., Nielsen, J. H., & Møldrup, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18686 · Cited by 66
Self-citationIntegrative Mitogenic Role of Protein Kinase B/Akt in β‐Cells
TRÜMPER, K., TRÜMPER, A., TRUSHEIM, H., ARNOLD, R., GÖKE, B., & HÖRSCH, D. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06972.x · Cited by 61
Swenne, I. (1985) · Diabetes · doi:10.2337/diab.34.8.803 · Cited by 61 · cited 1×
“Growth of the pancreatic -cell can be induced by multiple factors such as metabolites (glucose, amino acids) (41, 42), insulin (43), IGF-I (44), incretins (glucagon-like peptide-1 and glucose-dependent insulinotropic peptide) (45–47), and hormones of the GH family (PL, PRL, and GH) (9).”
BackgroundLahti, J. M., Li, H., & Kidd, V. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10859 · Cited by 50
Frasor, J. M., Park, K., Byers, M. J., Telleria, C. M., Kitamura, T., Yu-Lee, L.-Y., Djiane, J., Park-Sarge, O.-K., & Gibori, G. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.12.0745 · Cited by 46
Fleenor, D., Petryk, A., Driscoll, P., & Freemark, M. (2000) · Pediatric Research · doi:10.1203/00006450-200001000-00023 · Cited by 43
Møldrup, A., Ormandy, C. J., Nagano, M. C., Murthy, K. K., Banville, D. L., Tronche, F., & Kelly, P. A. (1996) · Molecular Endocrinology · doi:10.1210/mend.10.6.8776726 · Cited by 43 · cited 1×
“The pGL2–1A is generated by the insertion of the 5 -flanking region of PRLR exon 1A ( 462/ 81) into the pGL2-basic vector (35).”
MethodSelf-citationThe Role of Growth Hormone and Prolactin in Beta Cell Growth and Regeneration
Nielsen, J. H., Møldrup, A., Billestrup, N., Petersen, E. D., Allevato, G., & Stahl, M. M. S. (1992) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-3448-8_2 · Cited by 37
Self-citationAsfari, M., De, W., Postel-Vinay, M. C., & Czernichow, P. (1995) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)03445-y · Cited by 37
Møldrup, A., Billestrup, N., & Nielsen, J. H. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38943-4 · Cited by 35
Self-citationRapid Ca2+ Influx and Diacylglycerol Synthesis in Growth Hormone-mediated Islet β-Cell Mitogenesis
Sjöholm, Å., Zhang, Q., Welsh, N., Hansson, A., Larsson, O., Tally, M., & Berggren, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001212200 · Cited by 34
Burns, C. J., Squires, P. E., & Persaud, S. J. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2179 · Cited by 30
Møldrup, A. (1996) · Molecular Endocrinology · doi:10.1210/me.10.6.661 · Cited by 26
Self-citationPancreatic Growth and Regeneration
Sarvetnick, N. (1998) · KARGER eBooks · doi:10.1159/isbn.978-3-8055-6618-6 · Cited by 23
Characterization of the Murine Cyclin D2 Gene: Exon/Intron Organization and Promoter Activity
Jun, D. Y., Kim, M.-K., Kim, I.-G., & Kim, Y. H. (1997) · Molecules and Cells · doi:10.1016/s1016-8478(23)13334-6 · Cited by 19 · cited 2×
“Nuclear extracts were incubated with a radiolabeled double-stranded oligonucleotide representing a putative STAT5 binding element of the murine cyclin D2 promoter located at position 1129 to 1121 (39).”
BackgroundMethodMolecular basis for islet development, growth, and regeneration
Nielsen, J. H., & Serup, P. (1998) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-199804000-00005 · Cited by 18
Self-citationHennige, A. M., Fritsche, A., Strack, V., Weigert, C., Mischak, H., Borboni, P., Renn, W., Häring, H., & Kellerer, M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6144 · Cited by 16
Pancreatic Growth and Regeneration
Benbow, E. W. (1998) · Gut · doi:10.1136/gut.43.1.146f · Cited by 8
Mechanisms of Postnatal β-Cell Mass Regulation
Bonner‐Weir, S., & Weir, G. C. (2001) · Endocrine updates · doi:10.1007/978-1-4615-1669-9_17 · Cited by 2
Research works printed but not linked: 1
- Plachot, 2001, Reduced pancreatic beta-cell growth response to pregnancy correlates with impaired prolactin levels in the diabetic GK rat., Diabetes, 50, A340
Cited by
Regulation of Insulin Synthesis and Secretion and Pancreatic Beta-Cell Dysfunction in Diabetes
Fu, Z., R. Gilbert, E., & Liu, D. (2013) · Current Diabetes Reviews · doi:10.2174/157339913804143225 · Cited by 732
Regulation of pancreatic beta-cell mass
Bouwens, L., & Rooman, I. (2005) · Physiological Reviews · doi:10.1152/physrev.00025.2004 · Cited by 411
Expansion of β-cell mass in response to pregnancy
Rieck, S., & Kaestner, K. H. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.11.001 · Cited by 358
“Cish and Socs2 decrease activation of STAT5 [67,68], which has both pro-proliferative (Cyclin D2) [69] and anti-apoptotic (Bcl-xl, Bcl6) targets, as well as targets involved in β-cell function (Figure 3) [56,70].”
BackgroundCyclins D2 and D1 Are Essential for Postnatal Pancreatic β-Cell Growth
Kushner, J. A., Ciemerych, M. A., Sicinska, E., Wartschow, L. M., Teta, M., Long, S. Y., Sicinski, P., & White, M. F. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.9.3752-3762.2005 · Cited by 334
“Outstanding issues include how cyclin D2 is regulated in islets, although recent evidence suggests that growth hormonemediated islet growth may involve STAT5 regulation of the cyclin D2 promoter ( 9 ).”
BackgroundHuman β-Cell Proliferation and Intracellular Signaling
Kulkarni, R. N., Mizrachi, E.-B., Ocana, A. G., & Stewart, A. F. (2012) · Diabetes · doi:10.2337/db12-0018 · Cited by 236
Metadata
- Authors
- Friedrichsen, B. N., Richter, H. E., Hansen, J. A., Rhodes, C. J., Nielsen, J. H., Billestrup, N., & Møldrup, A.
- Affiliations
- Novo Nordisk (Denmark) (DK)
- Department of Signal Transduction (H.E.R., J.A.H., N.B.), Novo Nordisk A/S, 2820 Bagsværd, Denmark
- University of Washington (US)
- University of Copenhagen (DK)
- Department of Islet Discovery Research (B.N.F., A.M.), 2820 Bagsværd, Denmark
- Corresponding author
- Friedrichsen, Birgitte N.
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2003-05-01
- Volume
- 17
- Issue
- 5
- Pages
- 945-958
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- OpenAlex
- W2146296317
- Cited by
- 93
- References
- 78
- Citations by year
- 2025: 1 · 2023: 1 · 2022: 1 · 2020: 2 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 3 · 2014: 3 · 2013: 3 · 2012: 3
- FWCI
- 9.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- STAT5, cyclin D2, pancreatic beta-cell proliferation, growth hormone, INS-1 cells, cell cycle regulation, prolactin signaling
- MeSH terms
- Animals, Binding Sites, Cell Division, Cells, Cultured, DNA-Binding Proteins, Doxycycline, Gene Expression Regulation, Islets of Langerhans, Milk Proteins, Mutation, Promoter Regions, Genetic, Transcription, Genetic, Transcriptional Activation, Trans-Activators, Cyclins, Human Growth Hormone, STAT5 Transcription Factor, Mice, Rats, Cyclin D2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.